The notice published on November 3, 2016 is unrelated to proposed changes to the Common Rule. The notice is a request that the Office of Management and Budget (OMB) renew FDA’s existing information collection activities for various sections of FDA’s human subject protection and informed consent regulations found in 21 CFR 50 and 56.